nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0624	0.0752	CbGbCtD
Sulfasalazine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0605	0.073	CbGbCtD
Sulfasalazine—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0548	0.0661	CbGbCtD
Sulfasalazine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0548	0.066	CbGbCtD
Sulfasalazine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0548	0.066	CbGbCtD
Sulfasalazine—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0481	0.058	CbGbCtD
Sulfasalazine—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0481	0.058	CbGbCtD
Sulfasalazine—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0481	0.058	CbGbCtD
Sulfasalazine—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0435	0.0525	CbGbCtD
Sulfasalazine—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0435	0.0525	CbGbCtD
Sulfasalazine—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0417	0.0503	CbGbCtD
Sulfasalazine—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0357	0.043	CbGbCtD
Sulfasalazine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0352	0.0424	CbGbCtD
Sulfasalazine—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0323	0.0389	CbGbCtD
Sulfasalazine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0318	0.0383	CbGbCtD
Sulfasalazine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0318	0.0383	CbGbCtD
Sulfasalazine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0274	0.0331	CbGbCtD
Sulfasalazine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0266	0.0321	CbGbCtD
Sulfasalazine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0241	0.0291	CbGbCtD
Sulfasalazine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0241	0.0291	CbGbCtD
Sulfasalazine—TBXAS1—blood plasma—acquired immunodeficiency syndrome	0.00472	0.0405	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—acquired immunodeficiency syndrome	0.00426	0.865	CrCbGaD
Sulfasalazine—PLA2G1B—blood plasma—acquired immunodeficiency syndrome	0.00396	0.0339	CbGeAlD
Sulfasalazine—ACAT1—digestive system—acquired immunodeficiency syndrome	0.00217	0.0186	CbGeAlD
Sulfasalazine—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00206	0.0177	CbGeAlD
Sulfasalazine—CHUK—skin of body—acquired immunodeficiency syndrome	0.00202	0.0174	CbGeAlD
Sulfasalazine—PPARG—endothelium—acquired immunodeficiency syndrome	0.002	0.0172	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—acquired immunodeficiency syndrome	0.002	0.0172	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—acquired immunodeficiency syndrome	0.00199	0.0171	CbGeAlD
Sulfasalazine—ACAT1—vagina—acquired immunodeficiency syndrome	0.00192	0.0165	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—acquired immunodeficiency syndrome	0.00184	0.0158	CbGeAlD
Sulfasalazine—ACAT1—lung—acquired immunodeficiency syndrome	0.00181	0.0156	CbGeAlD
Sulfasalazine—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00178	0.0153	CbGeAlD
Sulfasalazine—TBXAS1—blood—acquired immunodeficiency syndrome	0.00173	0.0148	CbGeAlD
Sulfasalazine—ACAT1—nervous system—acquired immunodeficiency syndrome	0.00168	0.0144	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—acquired immunodeficiency syndrome	0.00167	0.0144	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00164	0.0141	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—acquired immunodeficiency syndrome	0.00164	0.0141	CbGeAlD
Sulfasalazine—SLC46A1—digestive system—acquired immunodeficiency syndrome	0.00162	0.0139	CbGeAlD
Sulfasalazine—CHUK—digestive system—acquired immunodeficiency syndrome	0.00162	0.0139	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—acquired immunodeficiency syndrome	0.00162	0.0139	CbGeAlD
Sulfasalazine—CHUK—blood—acquired immunodeficiency syndrome	0.00154	0.0132	CbGeAlD
Sulfasalazine—PLA2G1B—digestive system—acquired immunodeficiency syndrome	0.00152	0.0131	CbGeAlD
Sulfasalazine—TBXAS1—lung—acquired immunodeficiency syndrome	0.00152	0.013	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—acquired immunodeficiency syndrome	0.00148	0.0127	CbGeAlD
Sulfasalazine—PLA2G1B—blood—acquired immunodeficiency syndrome	0.00145	0.0124	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—acquired immunodeficiency syndrome	0.0014	0.012	CbGeAlD
Sulfasalazine—IKBKB—skin of body—acquired immunodeficiency syndrome	0.00137	0.0118	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—acquired immunodeficiency syndrome	0.00135	0.0116	CbGeAlD
Sulfasalazine—CHUK—lung—acquired immunodeficiency syndrome	0.00135	0.0116	CbGeAlD
Sulfasalazine—SLC7A11—digestive system—acquired immunodeficiency syndrome	0.00133	0.0114	CbGeAlD
Sulfasalazine—ACAT1—brain—acquired immunodeficiency syndrome	0.00128	0.011	CbGeAlD
Sulfasalazine—PLA2G1B—lung—acquired immunodeficiency syndrome	0.00127	0.0109	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—acquired immunodeficiency syndrome	0.00125	0.0107	CbGeAlD
Sulfasalazine—ACAT1—lymph node—acquired immunodeficiency syndrome	0.00124	0.0106	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—acquired immunodeficiency syndrome	0.00122	0.0105	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—acquired immunodeficiency syndrome	0.0012	0.0103	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—acquired immunodeficiency syndrome	0.00118	0.0101	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—acquired immunodeficiency syndrome	0.00113	0.00972	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.00111	0.00955	CbGeAlD
Sulfasalazine—SLC7A11—lung—acquired immunodeficiency syndrome	0.00111	0.00955	CbGeAlD
Sulfasalazine—IKBKB—digestive system—acquired immunodeficiency syndrome	0.0011	0.00944	CbGeAlD
Sulfasalazine—TBXAS1—brain—acquired immunodeficiency syndrome	0.00107	0.00921	CbGeAlD
Sulfasalazine—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00107	0.00919	CbGeAlD
Sulfasalazine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00106	0.00909	CbGeAlD
Sulfasalazine—IKBKB—blood—acquired immunodeficiency syndrome	0.00105	0.00899	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—acquired immunodeficiency syndrome	0.00104	0.0089	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—acquired immunodeficiency syndrome	0.00103	0.00884	CbGeAlD
Sulfasalazine—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00102	0.00879	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—acquired immunodeficiency syndrome	0.000992	0.00851	CbGeAlD
Sulfasalazine—IKBKB—vagina—acquired immunodeficiency syndrome	0.000971	0.00833	CbGeAlD
Sulfasalazine—CHUK—brain—acquired immunodeficiency syndrome	0.000956	0.00821	CbGeAlD
Sulfasalazine—SLC46A1—brain—acquired immunodeficiency syndrome	0.000956	0.00821	CbGeAlD
Sulfasalazine—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000951	0.00816	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—acquired immunodeficiency syndrome	0.000924	0.00793	CbGeAlD
Sulfasalazine—CHUK—lymph node—acquired immunodeficiency syndrome	0.000924	0.00793	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.000923	0.00792	CbGeAlD
Sulfasalazine—IKBKB—lung—acquired immunodeficiency syndrome	0.000918	0.00788	CbGeAlD
Sulfasalazine—ALOX5—digestive system—acquired immunodeficiency syndrome	0.000911	0.00782	CbGeAlD
Sulfasalazine—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000909	0.0078	CbGeAlD
Sulfasalazine—PLA2G1B—brain—acquired immunodeficiency syndrome	0.000899	0.00772	CbGeAlD
Sulfasalazine—ALOX5—blood—acquired immunodeficiency syndrome	0.000868	0.00745	CbGeAlD
Sulfasalazine—PPARG—skin of body—acquired immunodeficiency syndrome	0.000855	0.00734	CbGeAlD
Sulfasalazine—IKBKB—nervous system—acquired immunodeficiency syndrome	0.00085	0.0073	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.00084	0.00721	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.000819	0.00703	CbGeAlD
Sulfasalazine—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000793	0.00681	CbGeAlD
Sulfasalazine—SLC7A11—brain—acquired immunodeficiency syndrome	0.000787	0.00676	CbGeAlD
Sulfasalazine—ALOX5—lung—acquired immunodeficiency syndrome	0.000761	0.00653	CbGeAlD
Sulfasalazine—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000756	0.00649	CbGeAlD
Sulfasalazine—ALOX5—nervous system—acquired immunodeficiency syndrome	0.000705	0.00605	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000693	0.00595	CbGeAlD
Sulfasalazine—PPARG—digestive system—acquired immunodeficiency syndrome	0.000684	0.00587	CbGeAlD
Sulfasalazine—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.000679	0.00582	CbGeAlD
Sulfasalazine—Vismodegib—ALB—acquired immunodeficiency syndrome	0.000662	0.134	CrCbGaD
Sulfasalazine—PPARG—blood—acquired immunodeficiency syndrome	0.000652	0.00559	CbGeAlD
Sulfasalazine—IKBKB—brain—acquired immunodeficiency syndrome	0.00065	0.00558	CbGeAlD
Sulfasalazine—PPARG—bone marrow—acquired immunodeficiency syndrome	0.000631	0.00541	CbGeAlD
Sulfasalazine—IKBKB—lymph node—acquired immunodeficiency syndrome	0.000628	0.00539	CbGeAlD
Sulfasalazine—PPARG—vagina—acquired immunodeficiency syndrome	0.000604	0.00519	CbGeAlD
Sulfasalazine—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000601	0.00516	CbGeAlD
Sulfasalazine—ABCC2—blood—acquired immunodeficiency syndrome	0.000573	0.00492	CbGeAlD
Sulfasalazine—PPARG—lung—acquired immunodeficiency syndrome	0.000571	0.0049	CbGeAlD
Sulfasalazine—ALOX5—brain—acquired immunodeficiency syndrome	0.000539	0.00462	CbGeAlD
Sulfasalazine—PPARG—nervous system—acquired immunodeficiency syndrome	0.000529	0.00454	CbGeAlD
Sulfasalazine—ALOX5—lymph node—acquired immunodeficiency syndrome	0.000521	0.00447	CbGeAlD
Sulfasalazine—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000509	0.00437	CbGeAlD
Sulfasalazine—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000457	0.00392	CbGeAlD
Sulfasalazine—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000437	0.00375	CbGeAlD
Sulfasalazine—ABCG2—blood—acquired immunodeficiency syndrome	0.000418	0.00359	CbGeAlD
Sulfasalazine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000407	0.00349	CbGeAlD
Sulfasalazine—PPARG—brain—acquired immunodeficiency syndrome	0.000404	0.00347	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000404	0.00347	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000403	0.00345	CbGeAlD
Sulfasalazine—PPARG—lymph node—acquired immunodeficiency syndrome	0.000391	0.00335	CbGeAlD
Sulfasalazine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000388	0.00333	CbGeAlD
Sulfasalazine—ABCG2—vagina—acquired immunodeficiency syndrome	0.000387	0.00332	CbGeAlD
Sulfasalazine—ABCG2—lung—acquired immunodeficiency syndrome	0.000366	0.00314	CbGeAlD
Sulfasalazine—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000366	0.00314	CbGeAlD
Sulfasalazine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00036	0.00309	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000354	0.00304	CbGeAlD
Sulfasalazine—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00035	0.003	CbGeAlD
Sulfasalazine—PTGS1—blood—acquired immunodeficiency syndrome	0.000348	0.00299	CbGeAlD
Sulfasalazine—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000344	0.00295	CbGeAlD
Sulfasalazine—CYP3A5—lung—acquired immunodeficiency syndrome	0.00034	0.00292	CbGeAlD
Sulfasalazine—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000336	0.00288	CbGeAlD
Sulfasalazine—PTGS2—blood—acquired immunodeficiency syndrome	0.000333	0.00286	CbGeAlD
Sulfasalazine—PTGS1—vagina—acquired immunodeficiency syndrome	0.000323	0.00277	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000322	0.00277	CbGeAlD
Sulfasalazine—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000321	0.00275	CbGeAlD
Sulfasalazine—PTGS2—vagina—acquired immunodeficiency syndrome	0.000309	0.00265	CbGeAlD
Sulfasalazine—PTGS1—lung—acquired immunodeficiency syndrome	0.000306	0.00262	CbGeAlD
Sulfasalazine—PTGS2—lung—acquired immunodeficiency syndrome	0.000292	0.00251	CbGeAlD
Sulfasalazine—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000283	0.00243	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00234	CbGeAlD
Sulfasalazine—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00027	0.00232	CbGeAlD
Sulfasalazine—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.00026	0.00223	CbGeAlD
Sulfasalazine—ABCG2—brain—acquired immunodeficiency syndrome	0.000259	0.00223	CbGeAlD
Sulfasalazine—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000251	0.00215	CbGeAlD
Sulfasalazine—PTGS1—brain—acquired immunodeficiency syndrome	0.000216	0.00186	CbGeAlD
Sulfasalazine—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000209	0.00179	CbGeAlD
Sulfasalazine—PTGS2—brain—acquired immunodeficiency syndrome	0.000207	0.00177	CbGeAlD
Sulfasalazine—PTGS2—lymph node—acquired immunodeficiency syndrome	0.0002	0.00171	CbGeAlD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000148	0.00301	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000147	0.00298	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000146	0.00296	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000139	0.00283	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000138	0.00281	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000137	0.00278	CbGpPWpGaD
Sulfasalazine—SLC7A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000137	0.00277	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000136	0.00277	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000131	0.00266	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000131	0.00265	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.00013	0.00265	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000129	0.00261	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000128	0.0026	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000127	0.00258	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000124	0.00252	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000124	0.00251	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000123	0.0025	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000119	0.00241	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000118	0.0024	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000118	0.0024	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000118	0.00239	CbGpPWpGaD
Sulfasalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.000114	0.00232	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000114	0.00232	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000114	0.00231	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000113	0.0023	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000113	0.00229	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00219	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000107	0.00217	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000107	0.00217	CbGpPWpGaD
Sulfasalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	0.000106	0.00215	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000104	0.00212	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000103	0.00209	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000103	0.00209	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.83e-05	0.002	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	9.46e-05	0.00192	CbGpPWpGaD
Sulfasalazine—SLC46A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.42e-05	0.00191	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	9.35e-05	0.0019	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	9.29e-05	0.00189	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TNF—acquired immunodeficiency syndrome	9.29e-05	0.00189	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	9.26e-05	0.00188	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	9.21e-05	0.00187	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	8.98e-05	0.00182	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	8.91e-05	0.00181	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	8.86e-05	0.0018	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	8.64e-05	0.00175	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MBL2—acquired immunodeficiency syndrome	8.48e-05	0.00172	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	8.42e-05	0.00171	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TNF—acquired immunodeficiency syndrome	8.42e-05	0.00171	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	8.35e-05	0.0017	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	8.33e-05	0.00169	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOBEC3G—acquired immunodeficiency syndrome	8.3e-05	0.00168	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.26e-05	0.00168	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	8.21e-05	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	8.21e-05	0.00167	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.19e-05	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.16e-05	0.00166	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	8.1e-05	0.00164	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	8.04e-05	0.00163	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—ALB—acquired immunodeficiency syndrome	8.02e-05	0.00163	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.95e-05	0.00161	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	7.87e-05	0.0016	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.83e-05	0.00159	CbGpPWpGaD
Sulfasalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	7.44e-05	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	7.43e-05	0.00151	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.4e-05	0.0015	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CCR5—acquired immunodeficiency syndrome	7.39e-05	0.0015	CbGpPWpGaD
Sulfasalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	7.36e-05	0.00149	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	7.33e-05	0.00149	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	7.29e-05	0.00148	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	7.22e-05	0.00147	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.21e-05	0.00146	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	7.09e-05	0.00144	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCNT1—acquired immunodeficiency syndrome	7.06e-05	0.00143	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	6.98e-05	0.00142	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	6.97e-05	0.00141	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.97e-05	0.00141	CbGpPWpGaD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.94e-05	0.00141	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.85e-05	0.00139	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	6.75e-05	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.73e-05	0.00137	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	6.68e-05	0.00136	CbGpPWpGaD
Sulfasalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	6.67e-05	0.00135	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—ALB—acquired immunodeficiency syndrome	6.66e-05	0.00135	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.65e-05	0.00135	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ACTG1—acquired immunodeficiency syndrome	6.63e-05	0.00134	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	6.6e-05	0.00134	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	6.57e-05	0.00133	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	6.55e-05	0.00133	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—IL2—acquired immunodeficiency syndrome	6.5e-05	0.00132	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	6.49e-05	0.00132	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	6.48e-05	0.00131	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.43e-05	0.00131	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.42e-05	0.0013	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	6.32e-05	0.00128	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.32e-05	0.00128	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.21e-05	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	6.21e-05	0.00126	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.2e-05	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	6.15e-05	0.00125	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	6.13e-05	0.00124	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ACTG1—acquired immunodeficiency syndrome	6.01e-05	0.00122	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	5.99e-05	0.00121	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	5.96e-05	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	5.91e-05	0.0012	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.86e-05	0.00119	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.82e-05	0.00118	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	5.76e-05	0.00117	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.74e-05	0.00117	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	5.63e-05	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	5.63e-05	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.58e-05	0.00113	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	5.56e-05	0.00113	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	5.56e-05	0.00113	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.52e-05	0.00112	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	5.48e-05	0.00111	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MBL2—acquired immunodeficiency syndrome	5.45e-05	0.00111	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	5.39e-05	0.00109	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	5.36e-05	0.00109	CbGpPWpGaD
Sulfasalazine—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.34e-05	0.00108	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	5.3e-05	0.00108	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	5.15e-05	0.00105	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—ALB—acquired immunodeficiency syndrome	5.05e-05	0.00102	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	5.04e-05	0.00102	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	5.02e-05	0.00102	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	5.01e-05	0.00102	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.97e-05	0.00101	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	4.97e-05	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.96e-05	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.95e-05	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	4.95e-05	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.94e-05	0.001	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.94e-05	0.001	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MBL2—acquired immunodeficiency syndrome	4.94e-05	0.001	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.92e-05	0.000998	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.87e-05	0.000988	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.84e-05	0.000982	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	4.84e-05	0.000982	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.82e-05	0.000977	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.77e-05	0.000968	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	4.74e-05	0.000962	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	4.66e-05	0.000947	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CD4—acquired immunodeficiency syndrome	4.64e-05	0.000942	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.55e-05	0.000923	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	4.54e-05	0.000922	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.51e-05	0.000914	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.5e-05	0.000913	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.49e-05	0.000912	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.48e-05	0.000909	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.48e-05	0.000909	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.47e-05	0.000907	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	4.45e-05	0.000904	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	4.43e-05	0.0009	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.41e-05	0.000896	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	4.41e-05	0.000895	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—ALB—acquired immunodeficiency syndrome	4.41e-05	0.000895	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.39e-05	0.000891	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.38e-05	0.000889	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.33e-05	0.000878	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.28e-05	0.000868	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CCR2—acquired immunodeficiency syndrome	4.27e-05	0.000867	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	4.19e-05	0.000851	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	4.18e-05	0.000848	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	4.13e-05	0.000838	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.13e-05	0.000838	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.13e-05	0.000838	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	4.11e-05	0.000835	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.09e-05	0.000831	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.06e-05	0.000823	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.05e-05	0.000822	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.04e-05	0.00082	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000806	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	3.87e-05	0.000786	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNA1—acquired immunodeficiency syndrome	3.84e-05	0.00078	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.74e-05	0.00076	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD79A—acquired immunodeficiency syndrome	3.73e-05	0.000758	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CXCR4—acquired immunodeficiency syndrome	3.71e-05	0.000752	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ALB—acquired immunodeficiency syndrome	3.68e-05	0.000747	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.66e-05	0.000742	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.63e-05	0.000736	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	3.49e-05	0.000708	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	3.38e-05	0.000687	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.38e-05	0.000687	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.05e-05	0.00062	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—acquired immunodeficiency syndrome	3.04e-05	0.000618	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—acquired immunodeficiency syndrome	3.01e-05	0.000611	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CSF2—acquired immunodeficiency syndrome	3.01e-05	0.000611	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.97e-05	0.000602	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—acquired immunodeficiency syndrome	2.89e-05	0.000587	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.89e-05	0.000587	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.86e-05	0.000581	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.86e-05	0.000579	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.85e-05	0.000579	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.85e-05	0.000578	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.81e-05	0.000571	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.77e-05	0.000562	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.76e-05	0.00056	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	2.76e-05	0.00056	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	2.73e-05	0.000554	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	2.73e-05	0.000554	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.72e-05	0.000551	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.69e-05	0.000546	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	2.62e-05	0.000533	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	2.61e-05	0.000529	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.6e-05	0.000527	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.6e-05	0.000527	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.59e-05	0.000527	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.58e-05	0.000524	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.55e-05	0.000518	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCR5—acquired immunodeficiency syndrome	2.54e-05	0.000516	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.54e-05	0.000516	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.51e-05	0.00051	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000509	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.5e-05	0.000508	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.4e-05	0.000487	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.35e-05	0.000478	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.35e-05	0.000478	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000446	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.02e-05	0.000409	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000401	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.95e-05	0.000395	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000393	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000363	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—acquired immunodeficiency syndrome	1.79e-05	0.000363	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000361	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.000358	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—acquired immunodeficiency syndrome	1.73e-05	0.000351	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	1.62e-05	0.000329	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	1.61e-05	0.000328	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.000327	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000326	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—acquired immunodeficiency syndrome	1.6e-05	0.000324	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—acquired immunodeficiency syndrome	1.59e-05	0.000323	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	1.57e-05	0.000318	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.000305	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.45e-05	0.000295	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	1.44e-05	0.000293	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	1.27e-05	0.000258	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	1.18e-05	0.000239	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-05	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000209	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	9.45e-06	0.000192	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—acquired immunodeficiency syndrome	9.35e-06	0.00019	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.32e-06	0.000189	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	8.98e-06	0.000182	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—acquired immunodeficiency syndrome	8.63e-06	0.000175	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	8.47e-06	0.000172	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	8.44e-06	0.000171	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.04e-06	0.000123	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.48e-06	0.000111	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	5.11e-06	0.000104	CbGpPWpGaD
